Clinical Utility of Homologous Recombination Deficiency (HRD) Profiling in Ovarian Cancer: An Indian Experience

被引：0

作者：

Bahadur, U. ^{[1
]}

Ravichandran, A. ^{[1
]}

Basu, S. ^{[1
]}

Nayanala, S. ^{[1
]}

Vishwanath, D. ^{[1
]}

Muniyappa, N. ^{[1
]}

Neelagandan, B. G. K. ^{[1
]}

Ramkumar, A. N. J. A. ^{[1
]}

Sajjad, S. ^{[1
]}

Nair, R. H. J. J. ^{[1
]}

Krishnan, G. ^{[1
]}

Ramanathan, V. G. R. A. ^{[1
]}

Chatterjee, A. ^{[1
]}

Sridharan, S. ^{[1
]}

Phalke, S. ^{[1
]}

Veeramachaneni, V. ^{[1
]}

机构：

[1] Strand Life Sci, Bangalore, Karnataka, India

来源：

JOURNAL OF MOLECULAR DIAGNOSTICS | 2023年 / 25卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

ST051

引用

页码：S106 / S106

页数：1

共 50 条

[1] Homologous recombination deficiency (HRD) in 543 ovarian cancer samples: A single center hands-on experience
Kotsakis, A.
Konstantoulakis, P.
Christopoulou, G.
Samara, S.
Oikonomaki, A.
Roumelioti, K.
Pachitsa, F.
Koinis, F.
Georgoulias, V.
ANNALS OF ONCOLOGY, 2022, 33 (07) : S813 - S813
[2] Homologous recombination deficiency (HRD) testing on ovarian cancer ascites: A feasibility study
Ranghiero, A.
Rocco, E. Guerini
Rappa, A.
Varcica, D.
Taormina, S. V.
Adorisio, R.
Marinucci, L.
Betella, I.
Aletti, G.
Colombo, N.
Fusco, N.
Casadio, C.
Di Tonno, C.
Barberis, M.
ANNALS OF ONCOLOGY, 2023, 34 : S717 - S717
[3] Homologous recombination deficiency (HRD) score and niraparib efficacy in high grade ovarian cancer
Haluska, P.
Timms, K. M.
AlHilli, M.
Wang, Y.
Hartman, A. M.
Jones, J.
Gutin, A.
Sangale, Z.
Neff, C.
Lynchbury, J.
Rudolph-Owen, L.
Becker, M. A.
Agarwal, S.
Wilcoxen, K. M.
EUROPEAN JOURNAL OF CANCER, 2014, 50 : 72 - 73
[4] Homologous recombination deficiency and ovarian cancer
Ledermann, Jonathan A.
Drew, Yvette
Kristeleit, Rebecca S.
EUROPEAN JOURNAL OF CANCER, 2016, 60 : 49 - 58
[5] Validation of genotype array analysis for the assessment of homologous recombination deficiency (HRD) in epithelial ovarian cancer
Schnaiter, Simon
Schamschula, Esther
Zschocke, Johannes
Fiegl, Heidi
Reimer, Daniel U.
Zeimet, Alain
Wimmer, Katharina
EUROPEAN JOURNAL OF HUMAN GENETICS, 2023, 31 : 555 - 556
[6] HOMOLOGOUS RECOMBINATION DEFICIENCY TESTING IN ADVANCED OVARIAN CANCER: DESCRIPTION OF THE ENGOT HRD EUROPEAN INITIATIVE
Pujade-Lauraine, E.
Christinat, Y.
D'incalci, M.
Schouten, P.
Buisson, A.
Heukamp, L. C.
Van Gorp, T.
Kramer, C.
Mckee, T.
Marchini, S.
Hahnen, E.
Saintigny, P.
Braicu, E. Ioana
Vergote, I. B.
Yaniz-Galende, E.
Ray-Coquard, I.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A208 - A208
[7] A new homologous recombination deficiency (HRD) test in ovarian cancer provides a high diagnostic yield
Kim, J.
Kwon, G. Y.
Baik, S.
Lee, S.
Oh, E.
Hong, J.
Kim, S.
Lee, K.
VIRCHOWS ARCHIV, 2022, 481 (SUPPL 1) : S113 - S114
[8] Global-screening array for the assessment of homologous recombination deficiency (HRD) in epithelial ovarian cancer
Schnaiter, Simon
Schamschula, Esther
Fiegl, Heidelinde
Reimer, Daniel
Zeimet, Alain
Zschocke, Johannes
Wimmer, Katharina
EUROPEAN JOURNAL OF HUMAN GENETICS, 2022, 30 (SUPPL 1) : 402 - 403
[9] Homologous Recombination Deficiency (HRD) Status in Rare Histotypes of Ovarian Carcinomas: A Single-Center Experience
Ciudino, Riccardo
Rosini, Francesca
Corradini, Angelo
Costantino, Alessia
Coluccelli, Sara
Maloberti, Thais
de Biase, Dario
Tallini, Giovanni
Santini, Donatella
De Leo, Antonio
LABORATORY INVESTIGATION, 2023, 103 (03) : S871 - S872
[10] Clinical Utility of Genomic Tests Evaluating Homologous Recombination Repair Deficiency (HRD) for Treatment Decisions in Early and Metastatic Breast Cancer
Galland, Loick
Roussot, Nicolas
Desmoulins, Isabelle
Mayeur, Didier
Kaderbhai, Coureche
Ilie, Silvia
Hennequin, Audrey
Reda, Manon
Albuisson, Juliette
Arnould, Laurent
Boidot, Romain
Truntzer, Caroline
Ghiringhelli, Francois
Ladoire, Sylvain
CANCERS, 2023, 15 (04)

← 1 2 3 4 5 →